Skip to main content
. 2022 Aug 12;13:939311. doi: 10.3389/fimmu.2022.939311

Table 1.

Comparison of baseline characteristics between the two vaccine groups.

Cohort 1 (n=68) Cohort 2 (n=69) p
Gender 0.336a
 Male 26 21
 Female 42 48
Age 0.105a
 18-42 40 30
 43-59 29 38
BMI 0.114
 <18.5 3 (4.4) 3 (4.3)
 18.5~23.9 51 (75.0) 39 (56.5)
 24.0~27.9 11 (16.2) 22 (31.9)
 ≥28.0 3 (4.4) 5 (7.2)
Smoke 0.520
 Always 6 (8.8) 5 (7.2)
 Sometimes 3 (4.4) 1 (1.4)
 Never 59 (86.6) 63 (91.3)
Alcohol 1.000
 Always 1 (1.5) 1 (1.4)
 Sometimes 12 (17.6) 13 (18.8)
 Never 55 (80.9) 55 (79.7)
Chronic respiratory diseases 0.619
 Yes 1 (1.5) 3 (4.3)
 No 67 (98.5) 66 (95.7)
Diabetes mellitus 1.000
 Yes 0 (0.0) 1 (1.4)
 No 68 (100.0) 68 (98.6)
Cardiovascular disease 0.208
 Yes 1 (1.5) 5 (7.2)
 No 67 (98.5) 64 (92.8)
Exercise 0.362a
 Always 14 (20.6) 13 (18.8)
 Sometimes 38 (55.9) 32 (46.4)
 Never 16 (23.5) 24 (34.8)
Resting 0.291
 Always insomnia 2 (2.9) 5 (7.2)
 Sometimes insomnia 16 (23.5) 21 (30.4)
 Regular 50 (73.5) 43 (62.3)
Vaccination history
Influenza 0.022
 Yes 34 (50.0) 46 (66.7)
 No 33 (48.5) 19 (27.5)
 Unclear 1 (1.5) 4 (5.8)
Hepatitis A/B 0.367
 Yes 41 (60.3) 45 (65.2)
 No 21 (30.9) 22 (31.9)
 Unclear 6 (8.8) 2 (2.9)
Mumps 1.000a
 Yes 9 (13.2) 10 (14.5)
 No 39 (57.4) 39 (56.6)
 Unclear 20 (29.4) 20 (29.0)
Rabies 0.329
 Yes 9 (13.2) 15 (21.7)
 No 57 (83.8) 50 (72.5)
 Unclear 2 (2.9) 4 (5.8)
Typhoid 0.016
 Yes 1 (1.5) 2 (2.9)
 No 57 (83.8) 44 (63.8)
 Unclear 10 (14.7) 23 (33.3)
Hemorrhagic fever 0.213
 Yes 1 (1.5) 1 (1.4)
 No 57 (83.8) 50 (72.5)
 Unclear 10 (14.7) 18 (26.1)

The comparison was analyzed by Fisher’s exact test unless it is marked with a Chi-squared test.